arrow
A

Anna DeFazio

the daffodil centre
H指数:75
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium

不同种族和族裔的侵袭性上皮性卵巢癌患者总生存期差异:卵巢癌协会联盟的研究结果

2026-06-300
OA
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma

BRCA缺陷性输卵管卵巢高级别浆液性癌的生存临床病理及分子预测因子

2026-04-010
OAAI
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary

全基因组测序提高了未知原发灶癌症的组织来源诊断和治疗选择。

2025-05-200
OA
Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival

输卵管卵巢高级别浆液性癌患者结局的临床与分子预测因子及特殊生存情况

2024-09-010
PRE
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
2024-08-050
OAAI
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

整合多组学分析以确定卵巢癌风险区域的遗传和功能机制

2024-06-016
PRE
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
2022-12-0135
OA
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary

DNA测序和基因表达谱的比较,以协助未知原发癌的起源组织诊断

2022-11-3013
OAAI
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

高级别浆液性卵巢癌中FOXJ1蛋白表达增加与总生存期改善相关: 卵巢肿瘤组织分析联盟研究

2022-11-023
OA
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

拷贝数变异是已知和新的风险位点的卵巢癌风险等位基因

2022-10-106
OAAI
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

高诊断前炎症相关风险评分与卵巢癌生存率降低相关

2022-02-073
OA
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas

经过验证的生物标志物检测证实,ARID1A丢失与MMR缺乏,CD8 TIL浸润混淆,并且在子宫内膜异位症相关的卵巢癌中没有独立的预后价值。

2022-02-0721
OA
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma
2022-01-1117
OA